fusajacuxejilyp.blogspot.com
But the merger, which places Carolinaq Commerce in the Carolina Trust marks the sixth time since the economid downturn began that a Charlotte metro bank has been acquired by a companh outside theimmediate area. In the same two startup banks in Charlotte also called it The trend signals a shift for theQueen City, even thoughu some say it’s only temporary. Charlotte, once the aggressot in bank acquisitions, is now a targe t for outsiders looking to gain a share of this lucrative The runoff began inlate 2007, when The Scottish Bank, a four-brancb operation here, was acquired by ., a largd community bank based in Columbia, S.C.
(The Scottish Bank has since been renamed North Carolina Bank Trust tomatch SCBT’s South Carolinw Bank & Trust.)
domingo, 9 de septiembre de 2012
sábado, 8 de septiembre de 2012
Qantas, Emirates Ink Partnership - Chauffeur Included - CNBC.com (blog)
guronelogoh.blogspot.com
Brisbane Times | Qantas, Emirates Ink Partnership - Chauffeur Included CNBC.com (blog) Qantas Airways on Thursday signed a 10-year partnership with Emirates. The move ends the Australian airline's long-term relationship with British Airways, as Qantas tries to lift its struggling international division, according to The Associated Press. T he Flying Kangaroo Hops From Singapore Hub |
jueves, 6 de septiembre de 2012
Rice group gets $1.25 million to study Ike effects - Houston Business Journal:
ikefageze.blogspot.com
The two-year grant will help the SeverStorm Prediction, Education and Evacuation from Disasters grouop compile information obtained from the Hurricane Ike experiencwe and, in turn, make recommendationsw to lawmakers, emergency managers, industry officials and homeowners on how to prepar e for future storms. Formed in SSPEED is a multi-institutional collaboration that aims to addressa deficiencies instorm prediction, disaster planning and evacuations for communities stretchintg from New Orleans to Brownsville, Texas. Partnerr institutions include the , The , , , Texas A& M University at Galveston, the , , the and the .
The firsf report about lessons learned from Ike is slatecd for release by the end of the A final report with recommendations will follow within two Inthe interim, meetings are planned with many including industry leaders and emergenc managers, to share and gather information. Housto n Endowment is a private, philanthropid foundation that contributes to charitable organizations andeducational institutions.
The two-year grant will help the SeverStorm Prediction, Education and Evacuation from Disasters grouop compile information obtained from the Hurricane Ike experiencwe and, in turn, make recommendationsw to lawmakers, emergency managers, industry officials and homeowners on how to prepar e for future storms. Formed in SSPEED is a multi-institutional collaboration that aims to addressa deficiencies instorm prediction, disaster planning and evacuations for communities stretchintg from New Orleans to Brownsville, Texas. Partnerr institutions include the , The , , , Texas A& M University at Galveston, the , , the and the .
The firsf report about lessons learned from Ike is slatecd for release by the end of the A final report with recommendations will follow within two Inthe interim, meetings are planned with many including industry leaders and emergenc managers, to share and gather information. Housto n Endowment is a private, philanthropid foundation that contributes to charitable organizations andeducational institutions.
miércoles, 5 de septiembre de 2012
FDA rejects Vanda Pharmaceuticals drug - Atlanta Business Chronicle:
ysynut.wordpress.com
Regulators said Vanda's schizophrenia drug called iloperidone which it hoped to brand as was "not approvable" -- a harsh blow to the compangy that its officials and some analysts have describecd as surprising and one that leaves Vandqa scrambling to figure out its next steps. In a lette to the company, the FDA acknowledged that Fanapta acted similarluy to another schizophrenia drug onthe ziprasidone, labeled as Geodon by , in a clinicap trial the local company passed in December one that had sent Vanda's stock prices soaring at the time.
But the agency said it wantedc Vanda to conduct further clinical tests on how Fanapta compares with another schizophrenia drug being sold onpharmacy shelves, citing in particular risperidone, marketeed as Risperdal by , and olanzapine, marketed as Zyprexz by Eli Lilly & Co. Inc. By shares of Vanda (NASDAQ: VNDA) had taken a roughlg 66 percent dive, losing $2.21 to settle at $1.143 apiece. Vanda officials said the FDA also asked the company to conduct another safety stud y on Fanapta to better gaugeits long-term effect s on patients taking doses of 20 to 24 milligramws a day.
The company said it plans to meet with the FDA in the comingg weeks to getmore explanation, especially since companyt leaders and analysts said Geodon didn't require a similar benchmark with another rival drug to win approvall seven years ago. "We're very surprised by this saidMihael Polymeropoulos, chief executive of Vanda, in an analyst conferencw call Monday morning to elaborate on the news.
"Therd are many things we have to discusxs with the agency that were not to our understanding from prior He saidthe FDA's call for more studiesx "is a bit inconsistent with the in-writing communicatiom to us," and could drag out Vanda's chancex for reaching the A comparative study with a marketed schizophreniq drug could take another year and a half, whils another safety study could last up to two more Polymeropoulos said. "We have already conductecd a study versus placeboo and anactive comparator," or competitivs drug, he said. "We do not understanrd why they would want us to add anothed study with anotherdrug ...
to establisj again the efficacyof iloperidone. ... This is the reaso n we want to meet with the agency and understandwhat they'r saying and why they're asking And both studies will ramp up costsd for the company at a time when observersw aren't sure it has enough in the bank to pass into next Vanda reported $65.6 million in cash on hand as of Monday morning. In its last clinical trial to test Fanapta'd effectiveness against Geodon, Vanda spent upwards of $35 While Polymeropoulos said he couldn't talk about anticipatex cash burn for the remainder of theyear -- a likely hot topic of discussion at the company's earninges announcement next week -- he confirmed that the companu didn't have enough cash to conduct the additional studies required by the FDA.
"If this drug cannot be approved, the survival of this companyt isin doubt," said Maggie Liu, an equity analysy with , which doesn't own Vanda shares. "What reallu happens to the company depends onthe company'xs management team." Indeed, that leavez fundraising options for Vanda slim, as it continues its delayer search for well-heeled partners to help fund its developmenf or considers selling other producy lines.
Vanda, which has now put its Fanaptas pipelineon hold, had pullefd back on a $100 million debt offering after its mere prospect sent its stock price plunging last And with this news from the FDA, Vanda could face a tougher time negotiating for beneficia terms in a partnership or selling stock for more analysts said. Except for its long-terkm lease to its 27,000-square-foot headquarters on Medicalp Center Drive, which expires in 2016, Vandsa officials said their other contracts are cancelable within60 days. "They only have cash for two more so how long can they last isanother thing," Liu confirming that layoffs may be imminent.
"This kind of negotiationn with the FDA canbe time-consuming. So for me, the immediatse concern is the company's solvency."
Regulators said Vanda's schizophrenia drug called iloperidone which it hoped to brand as was "not approvable" -- a harsh blow to the compangy that its officials and some analysts have describecd as surprising and one that leaves Vandqa scrambling to figure out its next steps. In a lette to the company, the FDA acknowledged that Fanapta acted similarluy to another schizophrenia drug onthe ziprasidone, labeled as Geodon by , in a clinicap trial the local company passed in December one that had sent Vanda's stock prices soaring at the time.
But the agency said it wantedc Vanda to conduct further clinical tests on how Fanapta compares with another schizophrenia drug being sold onpharmacy shelves, citing in particular risperidone, marketeed as Risperdal by , and olanzapine, marketed as Zyprexz by Eli Lilly & Co. Inc. By shares of Vanda (NASDAQ: VNDA) had taken a roughlg 66 percent dive, losing $2.21 to settle at $1.143 apiece. Vanda officials said the FDA also asked the company to conduct another safety stud y on Fanapta to better gaugeits long-term effect s on patients taking doses of 20 to 24 milligramws a day.
The company said it plans to meet with the FDA in the comingg weeks to getmore explanation, especially since companyt leaders and analysts said Geodon didn't require a similar benchmark with another rival drug to win approvall seven years ago. "We're very surprised by this saidMihael Polymeropoulos, chief executive of Vanda, in an analyst conferencw call Monday morning to elaborate on the news.
"Therd are many things we have to discusxs with the agency that were not to our understanding from prior He saidthe FDA's call for more studiesx "is a bit inconsistent with the in-writing communicatiom to us," and could drag out Vanda's chancex for reaching the A comparative study with a marketed schizophreniq drug could take another year and a half, whils another safety study could last up to two more Polymeropoulos said. "We have already conductecd a study versus placeboo and anactive comparator," or competitivs drug, he said. "We do not understanrd why they would want us to add anothed study with anotherdrug ...
to establisj again the efficacyof iloperidone. ... This is the reaso n we want to meet with the agency and understandwhat they'r saying and why they're asking And both studies will ramp up costsd for the company at a time when observersw aren't sure it has enough in the bank to pass into next Vanda reported $65.6 million in cash on hand as of Monday morning. In its last clinical trial to test Fanapta'd effectiveness against Geodon, Vanda spent upwards of $35 While Polymeropoulos said he couldn't talk about anticipatex cash burn for the remainder of theyear -- a likely hot topic of discussion at the company's earninges announcement next week -- he confirmed that the companu didn't have enough cash to conduct the additional studies required by the FDA.
"If this drug cannot be approved, the survival of this companyt isin doubt," said Maggie Liu, an equity analysy with , which doesn't own Vanda shares. "What reallu happens to the company depends onthe company'xs management team." Indeed, that leavez fundraising options for Vanda slim, as it continues its delayer search for well-heeled partners to help fund its developmenf or considers selling other producy lines.
Vanda, which has now put its Fanaptas pipelineon hold, had pullefd back on a $100 million debt offering after its mere prospect sent its stock price plunging last And with this news from the FDA, Vanda could face a tougher time negotiating for beneficia terms in a partnership or selling stock for more analysts said. Except for its long-terkm lease to its 27,000-square-foot headquarters on Medicalp Center Drive, which expires in 2016, Vandsa officials said their other contracts are cancelable within60 days. "They only have cash for two more so how long can they last isanother thing," Liu confirming that layoffs may be imminent.
"This kind of negotiationn with the FDA canbe time-consuming. So for me, the immediatse concern is the company's solvency."
lunes, 3 de septiembre de 2012
Death penalty is unfairly applied - Yuma Sun
ejyceh.wordpress.com
Death penalty is unfairly applied Yuma Sun Death penalty is unfairly applied. September 03, 2012 5:15 PM. | Print Story | E-Mail Story. This letter is in response to Alfred Green's letter titled “Tucson murderer rewarded for crime.†The argument is not whether Jared Loughner deserves the death ... |
domingo, 2 de septiembre de 2012
Comment - Dallas Business Journal:
ejyceh.wordpress.com
Texas now faces a transportatioh crisis. We spend more of our lives in trafficv instead of withour families. We if ever, see major roadas built withouttoll booths. And the rail linesw and highway lane miles we know we need are beingv scaled back or scrapped in the face of a hopeless inability to payfor them. It is only becoming hardert to addressthese needs. The costs of steel and other basic road buildinbg materials have risenby 60% over the last five However, the state motor fuels tax our primary source of transportation funding — has been frozen at 20 centx per gallon since 1991. The disparitg has left the statee facing 21st century challengeas with a 20thcentury tool.
The Texas a group of the state’xs top thinkers and policymakers, focused on this issue at its annual publicv conference in Houstonon Dec. 3. And in January, the 81st Texasw Legislature will begin weighint opportunities to make a meaningful investmengin transportation. Here are alternatives that we believe the statsmust explore: • End transportation fundinf diversions. The has long provided money for the andothee priorities. We must focus this money on transportationb projects. • Use bond funding A year ago, Texans votedc to dedicate $5 billion in tax-supporter bonds to transportation projects.
The Legislatur should appropriate this money for its intendexd purpose and commit to using it with transparencyand • Support regional financing tools. Othe r than toll roads and privatization the state has provided few optionsfor cities, countiee and other local jurisdictions to fund The Legislature should offer new voter-approvee funding mechanisms for regions to plan and pay for rail lines and other projects. • Rewrite the gas tax. primary source of transportation funding cannot provider forthe state’s transportation needs.
The Legislature must have a seriouws debate about restructuring the motor fuelz tax to reflect the enormity of our taskd by indexing itto • Explore new Texas must move past a 20th century model that relies so heavily on single-occupancy vehicles and work to create a truly comprehensived statewide system for moving people and freight. This shouldd begin by funding the that voters overwhelmingly approvedin 2005. Reform the . With its overt advocacy of privatizationn and occasional disregard forthe Legislature, the department has rightlyg incurred the wrath of Texanxs and their representatives.
While we applaurd the department’s recent efforts to be more transparentgand accountable, the Legislature must fundamentally reforj the agency so that Texans are fully aware of its activitiee and never question its objectives.
Texas now faces a transportatioh crisis. We spend more of our lives in trafficv instead of withour families. We if ever, see major roadas built withouttoll booths. And the rail linesw and highway lane miles we know we need are beingv scaled back or scrapped in the face of a hopeless inability to payfor them. It is only becoming hardert to addressthese needs. The costs of steel and other basic road buildinbg materials have risenby 60% over the last five However, the state motor fuels tax our primary source of transportation funding — has been frozen at 20 centx per gallon since 1991. The disparitg has left the statee facing 21st century challengeas with a 20thcentury tool.
The Texas a group of the state’xs top thinkers and policymakers, focused on this issue at its annual publicv conference in Houstonon Dec. 3. And in January, the 81st Texasw Legislature will begin weighint opportunities to make a meaningful investmengin transportation. Here are alternatives that we believe the statsmust explore: • End transportation fundinf diversions. The has long provided money for the andothee priorities. We must focus this money on transportationb projects. • Use bond funding A year ago, Texans votedc to dedicate $5 billion in tax-supporter bonds to transportation projects.
The Legislatur should appropriate this money for its intendexd purpose and commit to using it with transparencyand • Support regional financing tools. Othe r than toll roads and privatization the state has provided few optionsfor cities, countiee and other local jurisdictions to fund The Legislature should offer new voter-approvee funding mechanisms for regions to plan and pay for rail lines and other projects. • Rewrite the gas tax. primary source of transportation funding cannot provider forthe state’s transportation needs.
The Legislature must have a seriouws debate about restructuring the motor fuelz tax to reflect the enormity of our taskd by indexing itto • Explore new Texas must move past a 20th century model that relies so heavily on single-occupancy vehicles and work to create a truly comprehensived statewide system for moving people and freight. This shouldd begin by funding the that voters overwhelmingly approvedin 2005. Reform the . With its overt advocacy of privatizationn and occasional disregard forthe Legislature, the department has rightlyg incurred the wrath of Texanxs and their representatives.
While we applaurd the department’s recent efforts to be more transparentgand accountable, the Legislature must fundamentally reforj the agency so that Texans are fully aware of its activitiee and never question its objectives.
sábado, 1 de septiembre de 2012
GM to identify 14 plant closures but probably not Wentzville - St. Louis Business Journal:
esivyjifag.wordpress.com
The announcement could coincidewith GM’s bankruptcy an unnamed source told The Associated Press. Four vehicled assembly plants, along with parts stamping, engine and transmissioh factories, will be shuttered, the AP reported. GM’sd plant in Wentzville, Mo., could be spared becauser it’s the only plant wherre Chevrolet Express and GMC Savana vansare made, said Haig an auto industry analysgt with . “I would think that they woulfd keep thatproduct going,” he said. “Ihn the long run they are commercial vehicles and therer is usefor them.
They are used for construction fleets for majorutilitt companies, independent contactors and electricians and shuttld vehicles.” If GM were to move Wentzville’as operations to another plant, it wouldr have to redesign the vans to fit the platfor of other vehicles because the vans do not shar e parts with light trucks, for Stoddard said. Robert Wheeler, a spokesman for GM’s Wentzvillr plant, said he does not know which facilities willbe closed. we will likely hear this news at the same he said.
A representative from United Auto Worker Local whichrepresents 1,700 workers at the Wentzville plant, was not immediatelhy available to comment because union memberws were busy voting Thursday on UAW contractt concessions.
The announcement could coincidewith GM’s bankruptcy an unnamed source told The Associated Press. Four vehicled assembly plants, along with parts stamping, engine and transmissioh factories, will be shuttered, the AP reported. GM’sd plant in Wentzville, Mo., could be spared becauser it’s the only plant wherre Chevrolet Express and GMC Savana vansare made, said Haig an auto industry analysgt with . “I would think that they woulfd keep thatproduct going,” he said. “Ihn the long run they are commercial vehicles and therer is usefor them.
They are used for construction fleets for majorutilitt companies, independent contactors and electricians and shuttld vehicles.” If GM were to move Wentzville’as operations to another plant, it wouldr have to redesign the vans to fit the platfor of other vehicles because the vans do not shar e parts with light trucks, for Stoddard said. Robert Wheeler, a spokesman for GM’s Wentzvillr plant, said he does not know which facilities willbe closed. we will likely hear this news at the same he said.
A representative from United Auto Worker Local whichrepresents 1,700 workers at the Wentzville plant, was not immediatelhy available to comment because union memberws were busy voting Thursday on UAW contractt concessions.
Suscribirse a:
Comentarios (Atom)